You are assessing a 36-week gestational age newborn immediately after birth. The newborn weighs 2200 g. On assessment, you find the newborn has good color, no retractions, no nasal flaring,
respiratory rate of 25 breaths/min, heart rate of 110 beats/min, and pulse oximetry of 96 on room air. Which of the following would you choose?
a. Calfactant
b. Albuterol
c. Beractant
d. No indication for drug therapy at this time
Question 2
__________ is a synthetic surfactant recently approved by the FDA for use in infants at risk for RDS.
a. Beractant
b. Calfactant
c. Lucinactant
d. Poractant alfa
